Cargando…

Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype

OBJECTIVE: Progressive myoclonic epilepsy type 1 (EPM1) is caused by biallelic alterations in the CSTB gene, most commonly dodecamer repeat expansions. Although transcranial magnetic stimulation (TMS)–induced long‐interval intracortical inhibition (LICI) was previously reported to be normal in EPM1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvennoinen, Katri, Säisänen, Laura, Hyppönen, Jelena, Rissanen, Saara M., Karjalainen, Pasi A., D'Ambrosio, Sasha, Jimenez‐Jimenez, Diego, Zagaglia, Sara, Rothwell, John C., Balestrini, Simona, Sisodiya, Sanjay M., Julkunen, Petro, Mervaala, Esa, Kälviäinen, Reetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107775/
https://www.ncbi.nlm.nih.gov/pubmed/36398398
http://dx.doi.org/10.1111/epi.17466
_version_ 1785026679899422720
author Silvennoinen, Katri
Säisänen, Laura
Hyppönen, Jelena
Rissanen, Saara M.
Karjalainen, Pasi A.
D'Ambrosio, Sasha
Jimenez‐Jimenez, Diego
Zagaglia, Sara
Rothwell, John C.
Balestrini, Simona
Sisodiya, Sanjay M.
Julkunen, Petro
Mervaala, Esa
Kälviäinen, Reetta
author_facet Silvennoinen, Katri
Säisänen, Laura
Hyppönen, Jelena
Rissanen, Saara M.
Karjalainen, Pasi A.
D'Ambrosio, Sasha
Jimenez‐Jimenez, Diego
Zagaglia, Sara
Rothwell, John C.
Balestrini, Simona
Sisodiya, Sanjay M.
Julkunen, Petro
Mervaala, Esa
Kälviäinen, Reetta
author_sort Silvennoinen, Katri
collection PubMed
description OBJECTIVE: Progressive myoclonic epilepsy type 1 (EPM1) is caused by biallelic alterations in the CSTB gene, most commonly dodecamer repeat expansions. Although transcranial magnetic stimulation (TMS)–induced long‐interval intracortical inhibition (LICI) was previously reported to be normal in EPM1, short‐interval intracortical inhibition (SICI) was reduced. We explored the association between these measures and the clinical and genetic features in a separate group of patients with EPM1. METHODS: TMS combined with electromyography was performed under neuronavigation. LICI was induced with an inter‐stimulus interval (ISI) of 100 ms, and SICI with ISIs of 2 and 3 ms, and their means (mSICIs) were expressed as the ratio of conditioned to unconditioned stimuli. LICI and mSICI were compared between patients and controls. Nonparametric correlation was used to study the association between inhibition and parameters of clinical severity, including the Unified Myoclonus Rating Scale (UMRS); among patients with EPM1 due to biallelic expansion repeats, also the association with the number of repeats was assessed. RESULTS: The study protocol was completed in 19 patients (15 with biallelic expansion repeats and 4 compound heterozygotes), and 7 healthy, age‐ and sex‐matched control participants. Compared to controls, patients demonstrated significantly less SICI (median mSICI ratio 1.18 vs 0.38; p < .001). Neither LICI nor SICI was associated with parameters of clinical severity. In participants with biallelic repeat expansions, the number of repeats in the more affected allele (greater repeat number [GRN]) correlated with LICI (rho = 0.872; p < .001) and SICI (rho = 0.689; p = .006). SIGNIFICANCE: Our results strengthen the finding of deranged γ‐aminobutyric acid (GABA)ergic inhibition in EPM1. LICI and SICI may have use as markers of GABAergic impairment in future trials of disease‐modifying treatment in this condition. Whether a higher number of expansion repeats leads to greater GABAergic impairment warrants further study.
format Online
Article
Text
id pubmed-10107775
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101077752023-04-18 Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype Silvennoinen, Katri Säisänen, Laura Hyppönen, Jelena Rissanen, Saara M. Karjalainen, Pasi A. D'Ambrosio, Sasha Jimenez‐Jimenez, Diego Zagaglia, Sara Rothwell, John C. Balestrini, Simona Sisodiya, Sanjay M. Julkunen, Petro Mervaala, Esa Kälviäinen, Reetta Epilepsia Research Articles OBJECTIVE: Progressive myoclonic epilepsy type 1 (EPM1) is caused by biallelic alterations in the CSTB gene, most commonly dodecamer repeat expansions. Although transcranial magnetic stimulation (TMS)–induced long‐interval intracortical inhibition (LICI) was previously reported to be normal in EPM1, short‐interval intracortical inhibition (SICI) was reduced. We explored the association between these measures and the clinical and genetic features in a separate group of patients with EPM1. METHODS: TMS combined with electromyography was performed under neuronavigation. LICI was induced with an inter‐stimulus interval (ISI) of 100 ms, and SICI with ISIs of 2 and 3 ms, and their means (mSICIs) were expressed as the ratio of conditioned to unconditioned stimuli. LICI and mSICI were compared between patients and controls. Nonparametric correlation was used to study the association between inhibition and parameters of clinical severity, including the Unified Myoclonus Rating Scale (UMRS); among patients with EPM1 due to biallelic expansion repeats, also the association with the number of repeats was assessed. RESULTS: The study protocol was completed in 19 patients (15 with biallelic expansion repeats and 4 compound heterozygotes), and 7 healthy, age‐ and sex‐matched control participants. Compared to controls, patients demonstrated significantly less SICI (median mSICI ratio 1.18 vs 0.38; p < .001). Neither LICI nor SICI was associated with parameters of clinical severity. In participants with biallelic repeat expansions, the number of repeats in the more affected allele (greater repeat number [GRN]) correlated with LICI (rho = 0.872; p < .001) and SICI (rho = 0.689; p = .006). SIGNIFICANCE: Our results strengthen the finding of deranged γ‐aminobutyric acid (GABA)ergic inhibition in EPM1. LICI and SICI may have use as markers of GABAergic impairment in future trials of disease‐modifying treatment in this condition. Whether a higher number of expansion repeats leads to greater GABAergic impairment warrants further study. John Wiley and Sons Inc. 2022-12-01 2023-01 /pmc/articles/PMC10107775/ /pubmed/36398398 http://dx.doi.org/10.1111/epi.17466 Text en © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Silvennoinen, Katri
Säisänen, Laura
Hyppönen, Jelena
Rissanen, Saara M.
Karjalainen, Pasi A.
D'Ambrosio, Sasha
Jimenez‐Jimenez, Diego
Zagaglia, Sara
Rothwell, John C.
Balestrini, Simona
Sisodiya, Sanjay M.
Julkunen, Petro
Mervaala, Esa
Kälviäinen, Reetta
Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
title Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
title_full Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
title_fullStr Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
title_full_unstemmed Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
title_short Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
title_sort short‐ and long‐interval intracortical inhibition in epm1 is related to genotype
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107775/
https://www.ncbi.nlm.nih.gov/pubmed/36398398
http://dx.doi.org/10.1111/epi.17466
work_keys_str_mv AT silvennoinenkatri shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT saisanenlaura shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT hypponenjelena shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT rissanensaaram shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT karjalainenpasia shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT dambrosiosasha shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT jimenezjimenezdiego shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT zagagliasara shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT rothwelljohnc shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT balestrinisimona shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT sisodiyasanjaym shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT julkunenpetro shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT mervaalaesa shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype
AT kalviainenreetta shortandlongintervalintracorticalinhibitioninepm1isrelatedtogenotype